p300/CBP-dependent and -independent transcriptional interference between NF-kappaB RelA and p53.

p53 and NF-kappaB RelA are activated by various genotoxic agents and mutually suppress each other's ability to activate transcription, most likely through competition for transcriptional coactivators such as CBP or p300. However, we found that the inhibition by RelA of p53 transcriptional activity is not completely restored by CBP/p300 overexpression and that a p53 mutant can not suppress RelA activity despite of its ability to bind CBP/p300. In the present study, we further present evidence that these two transcriptional factors directly interact both in vivo and in vitro. These results therefore indicate that the cross transcriptional interference between p53 and RelA is partly caused by the direct interaction between these two transcription factors which is mediated by their dimerization/tetramerization domains and results in inhibition of each other's transcriptional activity. Finally, cells derived from RelA knockout mice showed enhanced p53 transcriptional activity, suggesting that this cross transcriptional interference is physiologically important in cellular response to genotoxic stress.

[1]  W. El-Deiry,et al.  p53-mediated repression of nuclear factor-kappaB RelA via the transcriptional integrator p300. , 1998, Cancer research.

[2]  Masatoshi Hagiwara,et al.  Phosphorylated CREB binds specifically to the nuclear protein CBP , 1993, Nature.

[3]  J. Shay,et al.  A temperature‐sensitive mutant of human p53. , 1994, The EMBO journal.

[4]  A. Baldwin,et al.  Functional and physical associations between NF-kappa B and C/EBP family members: a Rel domain-bZIP interaction. , 1993, Molecular and cellular biology.

[5]  G. Franzoso,et al.  Structure, regulation and function of NF-kappa B. , 1994, Annual review of cell biology.

[6]  N. Perkins,et al.  Transcriptional Cross Talk between NF-κB and p53 , 1999, Molecular and Cellular Biology.

[7]  C. Prives,et al.  p53: puzzle and paradigm. , 1996, Genes & development.

[8]  K. Gardner,et al.  Recruitment of p300/CBP in p53-Dependent Signal Pathways , 1997, Cell.

[9]  Marty W. Mayo,et al.  TNF- and Cancer Therapy-Induced Apoptosis: Potentiation by Inhibition of NF-κB , 1996, Science.

[10]  J. Trent,et al.  WAF1, a potential mediator of p53 tumor suppression , 1993, Cell.

[11]  M. Daucher,et al.  Activation of the serum response factor by p65/NF‐kappaB. , 1996, The EMBO journal.

[12]  R. Wadgaonkar,et al.  CREB-binding Protein Is a Nuclear Integrator of Nuclear Factor-κB and p53 Signaling* , 1999, The Journal of Biological Chemistry.

[13]  David Baltimore,et al.  An Essential Role for NF-κB in Preventing TNF-α-Induced Cell Death , 1996, Science.

[14]  M. Jung,et al.  Correction of radiation sensitivity in ataxia telangiectasia cells by a truncated I kappa B-alpha. , 1995, Science.

[15]  Y. Obata,et al.  NF-κB RelA-deficient Lymphocytes: Normal Development of  T Cells and B Cells, Impaired Production of IgA and IgG1 and Reduced Proliferative Responses , 1997, The Journal of experimental medicine.

[16]  K. Kinzler,et al.  Oncogenic forms of p53 inhibit p53-regulated gene expression , 1992 .

[17]  K. Mitomo,et al.  A lymphoid cell-specific nuclear factor containing c-Rel-like proteins preferentially interacts with interleukin-6 kappa B-related motifs whose activities are repressed in lymphoid cells , 1992, Molecular and cellular biology.

[18]  T. Ikonen,et al.  Mutual Transcriptional Interference between RelA and Androgen Receptor* , 1996, The Journal of Biological Chemistry.

[19]  N. Sonenberg,et al.  Disruption of I kappa B alpha regulation by antisense RNA expression leads to malignant transformation. , 1994, Oncogene.

[20]  J B Lawrence,et al.  Molecular cloning and functional analysis of the adenovirus E1A-associated 300-kD protein (p300) reveals a protein with properties of a transcriptional adaptor. , 1994, Genes & development.

[21]  W. Greene,et al.  Cross‐coupling of the NF‐kappa B p65 and Fos/Jun transcription factors produces potentiated biological function. , 1993, The EMBO journal.

[22]  H. Kawai,et al.  Down-regulation of nuclear factor kappaB is required for p53-dependent apoptosis in X-ray-irradiated mouse lymphoma cells and thymocytes. , 1999, Cancer research.

[23]  M. Nerenberg,et al.  Ablation of transplanted HTLV-I tax-transformed tumors in mice by antisense inhibition of NF-kappa B. , 1992, Science.

[24]  X. Sun,et al.  Identification of a novel p53 promoter element involved in genotoxic stress-inducible p53 gene expression , 1995, Molecular and cellular biology.

[25]  E. Kalkhoven,et al.  Negative Interaction between the RelA(p65) Subunit of NF-B and the Progesterone Receptor (*) , 1996, The Journal of Biological Chemistry.

[26]  S. Ruben,et al.  Functional characterization of the NF-kappa B p65 transcriptional activator and an alternatively spliced derivative , 1992, Molecular and cellular biology.